Who / What
AstraZeneca plc (AZ) is a multinational pharmaceutical and biotechnology company. It is jointly British and Swedish, headquartered at the Cambridge Biomedical Campus in the United Kingdom, and focuses on therapeutics for major diseases.
Background & History
AstraZeneca was founded in 1999 through the merger of the Swedish company Astra AB and the British Zeneca Group. Zeneca originated from the 1993 demerger of Imperial Chemical Industries’ pharmaceutical operations. In the merger, Zeneca shareholders obtained 53.5 % of the new company and Astra shareholders 46.5 %.
Why Notable
AstraZeneca has a broad portfolio covering oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. Its dual heritage combines Swedish innovation and British research, making it a key contributor to global pharmaceutical development.
In the News
AstraZeneca continues to be a major player in pharmaceutical research and development across its core therapeutic areas. Its ongoing product pipeline keeps the company at the forefront of the industry.
